Oncolytics Biotech Inc.
NEWS
Although it was relatively quiet in COVID-19-related clinical trials, there was plenty of other clinical trial news. Here’s a look.
Pelareorep and FOLFIRI/B combination shows superior OS & PFS data in KRAS mutant colorectal cancer compared to historical data
Oncolytics Biotech® Inc. today announced a clinical collaboration with SOLTI, an academic research group dedicated to clinical and translational research in breast cancer.
When considering options in the biotech sector, experts often look more into the major companies providing massive amounts of resources to new candidates.
JOBS
IN THE PRESS